Larotinib

DRUG2 trials

Sponsors

Sunshine Lake Pharma Co., Ltd.

Conditions

Advanced Solid TumorEsophageal CancerHealthy Volunteers

Phase 1

Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function

Not yet recruitingNCT05048368

Sunshine Lake Pharma Co., Ltd.Advanced Solid Tumor, Esophageal Cancer

Start: 2026-10-30End: 2026-12-30Target: 32Updated: 2026-08-24

A Study to Evaluate Drug-Drug Interaction of Larotinib With Itraconazole and Rifampin in Healthy Adult Participants

CompletedNCT05057949

Sunshine Lake Pharma Co., Ltd.Healthy Volunteers

Start: 2021-11-24End: 2023-09-28Updated: 2025-05-18